Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients

Launched by PETER ATEF · Jan 27, 2022

Keywords

ClinConnect Summary

This clinical trial is studying whether measuring the flow of blood in the portal vein can help predict the presence of swollen veins in the esophagus, known as esophageal varices, in patients with liver cirrhosis. These varices can be a serious condition that may lead to bleeding, so being able to identify them early is very important. The trial is currently recruiting participants of all ages who either have cirrhosis with or without esophageal varices. However, individuals with certain conditions like liver cancer, blocked blood vessels in the liver, or severe liver-related confusion will not be eligible to join.

Participants in this study can expect to have their blood flow measured in a non-invasive way, which means there won't be any need for a camera examination of the esophagus. This trial aims to find a simpler and safer method to screen for esophageal varices, potentially reducing the need for more invasive procedures in the future. If you or someone you know has cirrhosis and is interested in participating, this study could offer valuable insights into managing this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • cirrhotic patients with oesophageal varices
• • cirrhotic patients without oesophageal varices
• Exclusion Criteria:
• • Patients with hepato-cellular carcinomas \[HCCs\], portal vein thrombosis, hepatic encephalopathy.
• • Patients with positive HCV antibody, but without liver cirrhosis diagnostic criteria